carbon monoxide has been researched along with Breast Cancer in 19 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Excerpt | Relevance | Reference |
---|---|---|
"Paclitaxel (PTX) is a first-line treatment in breast cancer, though resistance develops quickly and frequently." | 8.02 | Carbon Monoxide Inhibits Cytochrome P450 Enzymes CYP3A4/2C8 in Human Breast Cancer Cells, Increasing Sensitivity to Paclitaxel. ( Faull, KF; Janzen, C; Kawahara, B; Mascharak, PK, 2021) |
"Lentiviral silencing of CBS in human breast cancer cells attenuated GSH/GSSG, total GSH, nuclear factor erythroid 2-related factor 2 (Nrf2), and processes downstream of Nrf2 that promote GSH synthesis and regeneration of GSH from GSSG." | 5.46 | Attenuation of Antioxidant Capacity in Human Breast Cancer Cells by Carbon Monoxide through Inhibition of Cystathionine β-Synthase Activity: Implications in Chemotherapeutic Drug Sensitivity. ( Carrington, S; Faull, KF; Hu-Moore, K; Kawahara, B; Mascharak, PK; Moller, T; Sen, S, 2017) |
"Andrographolide (AP) is a diterpene lactone in the leaves and stem of Andrographis paniculata (Burm." | 5.39 | Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells. ( Chao, CY; Chen, HW; Hsu, YT; Li, CC; Lii, CK; Liu, KL; Lu, CY, 2013) |
"Paclitaxel (PTX) is a first-line treatment in breast cancer, though resistance develops quickly and frequently." | 4.02 | Carbon Monoxide Inhibits Cytochrome P450 Enzymes CYP3A4/2C8 in Human Breast Cancer Cells, Increasing Sensitivity to Paclitaxel. ( Faull, KF; Janzen, C; Kawahara, B; Mascharak, PK, 2021) |
" Women with breast cancer had lower lung diffusing capacity for carbon monoxide (DLCO), respiratory and limb muscle strength, and ventilatory thresholds during exercise compared with controls (all P < 0." | 3.83 | Respiratory Factors Contributing to Exercise Intolerance in Breast Cancer Survivors: A Case-Control Study. ( Dudgeon, DJ; Elbehairy, AF; Langer, D; Neder, JA; O'Donnell, DE; Webb, KA, 2016) |
"Lentiviral silencing of CBS in human breast cancer cells attenuated GSH/GSSG, total GSH, nuclear factor erythroid 2-related factor 2 (Nrf2), and processes downstream of Nrf2 that promote GSH synthesis and regeneration of GSH from GSSG." | 1.46 | Attenuation of Antioxidant Capacity in Human Breast Cancer Cells by Carbon Monoxide through Inhibition of Cystathionine β-Synthase Activity: Implications in Chemotherapeutic Drug Sensitivity. ( Carrington, S; Faull, KF; Hu-Moore, K; Kawahara, B; Mascharak, PK; Moller, T; Sen, S, 2017) |
"Andrographolide (AP) is a diterpene lactone in the leaves and stem of Andrographis paniculata (Burm." | 1.39 | Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells. ( Chao, CY; Chen, HW; Hsu, YT; Li, CC; Lii, CK; Liu, KL; Lu, CY, 2013) |
"Of interest, patients with breast cancer have been noted to have an increase in endogenous carbon monoxide production via upregulation of heme oxygenase-1 activity." | 1.39 | Plasmatic hypercoagulation in patients with breast cancer: role of heme oxygenase-1. ( Alger, PW; Ley, ML; Matika, RW; Nielsen, VG; Steinbrenner, EB; Waer, AL, 2013) |
"We selected a group of breast cancer patients in high-dose chemotherapy (HDCT) protocols who were at risk for pulmonary injury." | 1.33 | Intrabreath analysis of carbon monoxide uptake during exercise in patients at risk for lung injury. ( Folz, RJ; Huang, YC; Macintyre, NR; O'brien, SR; Vredenburgh, J, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (21.05) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (21.05) | 29.6817 |
2010's | 9 (47.37) | 24.3611 |
2020's | 2 (10.53) | 2.80 |
Authors | Studies |
---|---|
Guo, W | 1 |
Huang, S | 1 |
An, J | 1 |
Zhang, J | 2 |
Dong, F | 1 |
Dang, J | 1 |
Guan, Q | 1 |
Zhou, LL | 1 |
Li, YA | 1 |
Dong, YB | 1 |
Kawahara, B | 2 |
Faull, KF | 2 |
Janzen, C | 1 |
Mascharak, PK | 3 |
Moller, T | 1 |
Hu-Moore, K | 1 |
Carrington, S | 1 |
Sen, S | 1 |
Chao, CY | 1 |
Lii, CK | 1 |
Hsu, YT | 1 |
Lu, CY | 1 |
Liu, KL | 1 |
Li, CC | 1 |
Chen, HW | 1 |
Nielsen, VG | 1 |
Ley, ML | 1 |
Waer, AL | 1 |
Alger, PW | 1 |
Matika, RW | 1 |
Steinbrenner, EB | 1 |
Lee, WY | 1 |
Chen, YC | 2 |
Shih, CM | 1 |
Lin, CM | 1 |
Cheng, CH | 1 |
Chen, KC | 1 |
Lin, CW | 2 |
O'Donnell, DE | 1 |
Webb, KA | 1 |
Langer, D | 1 |
Elbehairy, AF | 1 |
Neder, JA | 1 |
Dudgeon, DJ | 1 |
Carrington, SJ | 1 |
Chakraborty, I | 1 |
Bernard, JM | 1 |
Chen, WC | 1 |
Kim, J | 1 |
Kim, E | 1 |
Silverman, P | 1 |
Overmoyer, B | 1 |
Cooper, BW | 1 |
Anthony, S | 1 |
Shenk, R | 1 |
Leeming, R | 1 |
Hanks, SH | 1 |
Lyons, JA | 1 |
Erven, K | 1 |
Weltens, C | 1 |
Nackaerts, K | 1 |
Fieuws, S | 1 |
Decramer, M | 1 |
Lievens, Y | 1 |
Huang, YC | 1 |
O'brien, SR | 1 |
Vredenburgh, J | 1 |
Folz, RJ | 1 |
Macintyre, NR | 1 |
Jaén, J | 1 |
Vázquez, G | 1 |
Alonso, E | 1 |
León, A | 1 |
Guerrero, R | 1 |
Almansa, JF | 1 |
Shen, SC | 1 |
Hou, WC | 1 |
Yang, LY | 1 |
Fan, M | 1 |
Marks, LB | 1 |
Lind, P | 1 |
Hollis, D | 1 |
Woel, RT | 1 |
Bentel, GG | 1 |
Anscher, MS | 1 |
Shafman, TD | 1 |
Coleman, RE | 1 |
Jaszczak, RJ | 1 |
Munley, MT | 1 |
Cavallin-Ståhl, E | 1 |
Mercke, C | 1 |
Lundh, B | 1 |
Weisberg, E | 1 |
Senler, TI | 1 |
Dean, WL | 1 |
Murray, LF | 1 |
Wittliff, JL | 1 |
Wilson, LD | 1 |
Oldham, SB | 1 |
Harding, BW | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Intensity Modulated Radiation Therapy for Breast Cancer: A Phase I Feasibility Study[NCT00594477] | Phase 1 | 100 participants (Actual) | Interventional | 2008-01-04 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for carbon monoxide and Breast Cancer
Article | Year |
---|---|
Smoking and reproductive health.
Topics: Adult; Age Factors; Animals; Breast Feeding; Breast Neoplasms; Carbon Monoxide; Child; Child, Presch | 1985 |
2 trials available for carbon monoxide and Breast Cancer
Article | Year |
---|---|
A phase II study of radiotherapy and concurrent paclitaxel chemotherapy in breast-conserving treatment for node-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carbon Monoxi | 2012 |
Relating radiation-induced regional lung injury to changes in pulmonary function tests.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carbon Monoxide; Dose-Response Relationship, Radia | 2001 |
16 other studies available for carbon monoxide and Breast Cancer
Article | Year |
---|---|
Ultrasound-Mediated Antitumor Therapy via Targeted Acoustic Release Carrier of Carbon Monoxide (TARC-CO).
Topics: Breast Neoplasms; Carbon Monoxide; Excipients; Female; Humans; Microbubbles; Ultrasonic Therapy; Ult | 2022 |
A nanoscale metal-organic framework for combined photodynamic and starvation therapy in treating breast tumors.
Topics: Boron Compounds; Breast Neoplasms; Carbon Monoxide; Female; Humans; Manganese; Metal-Organic Framewo | 2019 |
Carbon Monoxide Inhibits Cytochrome P450 Enzymes CYP3A4/2C8 in Human Breast Cancer Cells, Increasing Sensitivity to Paclitaxel.
Topics: Antineoplastic Agents; Breast Neoplasms; Carbon Monoxide; Cell Line, Tumor; Cell Survival; Chloramph | 2021 |
Attenuation of Antioxidant Capacity in Human Breast Cancer Cells by Carbon Monoxide through Inhibition of Cystathionine β-Synthase Activity: Implications in Chemotherapeutic Drug Sensitivity.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antioxidants; Breast Neoplasms; Carbon Monoxide; | 2017 |
Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells.
Topics: Bilirubin; Breast Neoplasms; Carbon Monoxide; Cell Line, Tumor; Cell Movement; Diterpenes; Enzyme In | 2013 |
Plasmatic hypercoagulation in patients with breast cancer: role of heme oxygenase-1.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Blood Coagulation Tests; Breast N | 2013 |
The induction of heme oxygenase-1 suppresses heat shock protein 90 and the proliferation of human breast cancer cells through its byproduct carbon monoxide.
Topics: Benzoquinones; Breast Neoplasms; Carbon Monoxide; Cell Line, Tumor; Cell Proliferation; Curcumin; En | 2014 |
Respiratory Factors Contributing to Exercise Intolerance in Breast Cancer Survivors: A Case-Control Study.
Topics: Breast Neoplasms; Cancer Survivors; Carbon Monoxide; Case-Control Studies; Dyspnea; Exercise Test; E | 2016 |
A Theranostic Two-Tone Luminescent PhotoCORM Derived from Re(I) and (2-Pyridyl)-benzothiazole: Trackable CO Delivery to Malignant Cells.
Topics: Benzothiazoles; Breast Neoplasms; Carbon Monoxide; Cell Line, Tumor; Crystallography, X-Ray; Drug Ca | 2016 |
Changes in pulmonary function up to 10 years after locoregional breast irradiation.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemothe | 2012 |
Intrabreath analysis of carbon monoxide uptake during exercise in patients at risk for lung injury.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Breath Tests; Capillaries; Carbon Monoxide; Exercise | 2006 |
Changes in pulmonary function after incidental lung irradiation for breast cancer: A prospective study.
Topics: Adult; Aged; Breast Neoplasms; Carbon Monoxide; Dose-Response Relationship, Radiation; Female; Force | 2006 |
Heme oxygenase-1 inhibits breast cancer invasion via suppressing the expression of matrix metalloproteinase-9.
Topics: Breast Neoplasms; Carbon Monoxide; Cell Line, Tumor; Cell Movement; Down-Regulation; Female; Heme Ox | 2008 |
Carbon monoxide production in patients with breast carcinoma.
Topics: Adult; Aged; Anemia; Breast Neoplasms; Carbon Monoxide; Erythrocyte Aging; Erythropoiesis; Female; H | 1976 |
Quantification of cytochrome P-450-dependent cyclohexane hydroxylase activity in normal and neoplastic reproductive tissues.
Topics: Animals; Breast Neoplasms; Carbon Monoxide; Cytochrome P-450 Enzyme System; Female; Humans; Hydroxyl | 1985 |
Cytochrome P450 and steroid 11beta-hydroxylation in mitochondria from human adrenal cortex.
Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Antimycin A; Breast Neoplasms; Carbon Monoxide; Cushing S | 1968 |